Withania somnifera water extract as a potential candidate for differentiation based therapy of human neuroblastomas.
Neuroblastoma is an aggressive childhood disease of the sympathetic nervous system. Treatments are often ineffective and have serious side effects. Conventional therapy of neuroblastoma includes the differentiation agents. Unlike chemo-radiotherapy, differentiation therapy shows minimal side effects...
Main Authors: | Hardeep Kataria, Renu Wadhwa, Sunil C Kaul, Gurcharan Kaur |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3561198?pdf=render |
Similar Items
-
Water extract from the leaves of Withania somnifera protect RA differentiated C6 and IMR-32 cells against glutamate-induced excitotoxicity.
by: Hardeep Kataria, et al.
Published: (2012-01-01) -
Withania somnifera as a potential candidate to ameliorate high fat diet-induced anxiety and neuroinflammation
by: Taranjeet Kaur, et al.
Published: (2017-10-01) -
Evaluation and selection of candidate reference genes for normalization of quantitative RT-PCR in Withania somnifera (L.) Dunal.
by: Varinder Singh, et al.
Published: (2015-01-01) -
Assessment of bio-activities of the crude extract and components of Withania somnifera leaves by bioinformatics
by: Nashi widodo, et al.
Published: (2010-10-01) -
Triethylene glycol, an active component of Ashwagandha (Withania somnifera) leaves, is responsible for sleep induction.
by: Mahesh K Kaushik, et al.
Published: (2017-01-01)